Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹89Cr
Rev Gr TTM
Revenue Growth TTM
32.08%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

LYKISLTD
VS
| Quarter | Jun 2023 | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 6.2 | -15.9 | -11.1 | -15.7 | -20.5 | -15.4 | -15.1 | -48.9 | -7.8 | 6.8 | 14.4 | 136.7 |
| 88 | 95 | 91 | 121 | 71 | 82 | 76 | 61 | 67 | 87 | 88 | 142 |
Operating Profit Operating ProfitCr |
| 3.6 | 3.7 | 2.7 | -0.2 | 3.1 | 2.4 | 4.7 | 0.1 | 0.1 | 3.4 | 3.0 | 2.7 |
Other Income Other IncomeCr | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
Interest Expense Interest ExpenseCr | 3 | 2 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 2 | 1 | -1 | 1 | 1 | 2 | 0 | 0 | 3 | 2 | 4 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 |
|
Growth YoY PAT Growth YoY% | 33.7 | -42.0 | -74.1 | -113.2 | -31.1 | -54.9 | 9.2 | 10.4 | -156.1 | 226.1 | 27.7 | 382.6 |
| 1.3 | 2.1 | 1.5 | -0.6 | 1.1 | 1.1 | 2.0 | -1.1 | -0.7 | 3.4 | 2.2 | 1.3 |
| 0.6 | 1.1 | 0.7 | -0.4 | 0.4 | 0.5 | 0.8 | -0.3 | -0.2 | 1.6 | 1.0 | 1.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|
|
| | -36.4 | 0.3 | 38.2 | -0.9 | -42.6 | -24.9 | 419.9 | 38.0 | -10.9 | -26.5 | 32.1 |
| 166 | 105 | 110 | 149 | 147 | 85 | 67 | 329 | 429 | 395 | 290 | 383 |
Operating Profit Operating ProfitCr |
| 1.0 | 2.1 | -2.7 | -0.7 | 0.2 | -1.1 | -5.3 | -0.1 | 5.5 | 2.3 | 2.5 | 2.5 |
Other Income Other IncomeCr | 1 | 1 | 3 | 3 | 1 | 2 | 1 | 6 | 3 | 3 | 3 | 4 |
Interest Expense Interest ExpenseCr | 2 | 2 | 3 | 5 | 2 | 2 | 2 | 3 | 6 | 8 | 6 | 4 |
Depreciation DepreciationCr | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 |
| 0 | 1 | -3 | -4 | -2 | -1 | -5 | 2 | 20 | 4 | 3 | 8 |
| 0 | 1 | 0 | 0 | 1 | 0 | -3 | 0 | 4 | 0 | 1 | 2 |
|
| | 234.2 | -1,198.5 | -4.4 | 32.5 | 48.5 | -93.2 | 200.4 | 550.7 | -75.3 | -32.8 | 148.3 |
| 0.1 | 0.3 | -3.2 | -2.4 | -1.6 | -1.5 | -3.8 | 0.7 | 3.5 | 1.0 | 0.9 | 1.6 |
| 0.1 | 0.2 | -1.8 | -1.9 | -1.3 | -1.0 | -3.5 | 1.3 | 8.1 | 2.0 | 1.4 | 3.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|
Equity Capital Equity CapitalCr | 19 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 |
| 5 | 8 | 3 | -3 | -2 | -4 | -10 | -8 | 8 | 12 | 14 | 21 |
Current Liabilities Current LiabilitiesCr | 78 | 75 | 96 | 155 | 69 | 57 | 69 | 120 | 153 | 106 | 55 | 148 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 1 | 0 | 0 | 11 | 2 | 9 | 3 | 5 | 4 | 2 | 1 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 88 | 84 | 105 | 157 | 83 | 59 | 67 | 127 | 178 | 133 | 85 | 154 |
Non Current Assets Non Current AssetsCr | 14 | 20 | 14 | 15 | 14 | 16 | 21 | 8 | 7 | 8 | 6 | 36 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|
Operating Cash Flow Operating Cash FlowCr | -22 | 15 | -33 | 2 | 36 | 9 | -22 | -64 | -23 | 66 | 57 | -32 |
Investing Cash Flow Investing Cash FlowCr | 4 | -8 | 9 | 0 | 2 | 0 | 9 | 10 | 0 | -1 | -5 | -29 |
Financing Cash Flow Financing Cash FlowCr | 16 | -6 | 33 | 23 | -68 | -8 | 13 | 58 | 21 | -63 | -51 | 62 |
|
Free Cash Flow Free Cash FlowCr | -23 | 13 | -34 | 1 | 35 | 9 | -22 | -64 | -24 | 66 | 57 | |
| -23,754.9 | 4,878.8 | 970.7 | -45.5 | -1,487.5 | -736.4 | 908.7 | -2,654.1 | -149.2 | 1,708.6 | 2,179.2 | -496.4 |
CFO To EBITDA CFO To EBITDA% | -1,283.9 | 674.1 | 1,155.0 | -158.1 | 13,728.6 | -953.6 | 659.8 | 26,853.7 | -94.8 | 713.7 | 768.6 | -329.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 105 | 126 | 94 | 83 | 44 | 29 | 51 | 57 | 123 | 87 | 52 | 82 |
Price To Earnings Price To Earnings | 948.3 | 382.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 24.2 | 8.0 | 23.0 | 20.5 | 12.7 |
Price To Sales Price To Sales | 0.6 | 1.2 | 0.9 | 0.6 | 0.3 | 0.3 | 0.8 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 |
Price To Book Price To Book | 4.6 | 4.7 | 4.3 | 5.2 | 2.5 | 1.9 | 5.5 | 4.9 | 4.6 | 2.8 | 1.6 | 2.0 |
| 92.6 | 75.3 | -56.2 | -144.9 | 285.4 | -56.4 | -29.5 | -678.5 | 10.6 | 18.2 | 11.1 | 18.4 |
Profitability Ratios Profitability Ratios |
| 11.8 | 18.9 | 15.2 | 14.2 | 17.9 | 12.1 | 10.0 | 13.5 | 15.5 | 11.5 | 14.3 | 12.0 |
| 1.0 | 2.1 | -2.7 | -0.7 | 0.2 | -1.1 | -5.3 | -0.1 | 5.5 | 2.3 | 2.5 | 2.5 |
| 0.1 | 0.3 | -3.2 | -2.4 | -1.6 | -1.5 | -3.8 | 0.7 | 3.5 | 1.0 | 0.9 | 1.6 |
| 2.5 | 3.7 | -0.3 | 1.0 | 0.8 | 1.8 | -4.9 | 4.0 | 15.1 | 9.3 | 11.9 | 8.4 |
| 0.4 | 1.1 | -15.1 | -21.6 | -13.2 | -7.7 | -25.1 | 20.5 | 57.0 | 12.3 | 7.7 | 15.9 |
| 0.1 | 0.3 | -2.9 | -2.1 | -2.5 | -1.6 | -2.7 | 1.8 | 8.5 | 2.8 | 2.9 | 3.4 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Lykis Limited is a **BSE-listed** Indian enterprise specializing in the manufacturing, trading, and global distribution of **FMCG**, **Personal Care**, and **Food & Beverage** products. Recognized as a **Three Star Export House** by the DGFT, the company operates an extensive international network spanning over **40 countries** across Africa, Asia, Europe, and North America. The company is currently undergoing a transformative **Change in Control** following a strategic acquisition in late **2025**.
---
### **Diversified Product Portfolio & Market Verticals**
Lykis operates a dual business model comprising proprietary brand distribution and **Private Label/Contract Manufacturing** for international retailers. Its portfolio is strategically pivoted toward **Essential Goods** and **Preventive Healthcare**.
| Segment | Key Product Categories & Brands |
| :--- | :--- |
| **Personal Care** | **Oral Care:** Charcoal 3-in-1, Clove, Herbal, and Himalayan Pink Salt variants under **Tri-Active**, **Carvao**, and **Gratis**. <br> **Hair & Skin:** Body milk, petroleum jelly, hair colors, and styling gels under **Lykis**, **Bonita**, and **Rox**. |
| **Food & Beverages** | **Confectionery:** **Winky Pop** and **Jolly Pop** lollipops; **Yogo Twist** candies. <br> **Biscuits:** Glucose, Coconut, and Choco Chip cookies. <br> **Processed Foods:** **Polo Star** sardines, peanut butter, and canned vegetables. |
| **Baby Care** | **Monami Range:** Comprehensive suite including wipes, soaps, shampoos, and mosquito repellent roll-ons. |
| **Fragrances** | Premium perfumes and deodorants under the **Rox**, **Galaxy**, and **Whiskey Perfume** labels. |
| **Liquors & Commodities** | **Liquors:** Blended Whiskies and flavored Vodkas. <br> **Commodities:** Sugar, Rice, and industrial raw materials like **Extra Neutral Alcohol (ENA)** and **Glycerin**. |
---
### **Strategic Ownership Transition & "Open Offer" Dynamics**
As of **December 2025**, Lykis Limited entered a definitive transition phase following a **Share Purchase Agreement (SPA)** and a subsequent mandatory **Open Offer**.
* **New Promoter Group:** The acquisition is led by **Parshav Vatika LLP** (Acquirer) along with **K8 Products LLP** and **Tidagela Ventures Pvt Ltd** (PACs).
* **Acquisition Terms:** The Acquirers agreed to purchase **1,30,14,966 shares** (**67.17%** of voting capital) at **₹19.01** per share via SPA.
* **Open Offer Details:** To comply with SEBI regulations, an offer was made for an additional **26%** of voting capital (**50,37,541 shares**) at a price of **₹34.50** per share.
* **Compliance Mandate:** Post-transaction, public shareholding may drop to **6.83%**. The new promoters are contractually and legally bound to restore the **Minimum Public Shareholding (MPS)** to **25%** within statutory timelines.
* **Management Intent:** The incoming leadership intends to leverage their expertise in **logistics and distribution** to scale the existing FMCG business. They have committed to a **two-year moratorium** on disposing of significant company assets outside the ordinary course of business.
---
### **Financial Performance & Asset Rationalization**
The company has recently focused on cleaning its balance sheet and streamlining operations by exiting non-core associate ventures.
**Consolidated Financial Summary:**
| Metric (₹ in Crore) | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :---: | :---: | :---: |
| **Total Revenue** | **301.41** | **407.74** | **456.62** |
| **Profit After Tax (PAT)** | **2.61** | **3.88** | **15.73** |
| **Foreign Exchange Earnings** | **382.26** | - | - |
**Key Financial Developments:**
* **Revenue Volatility:** The decline in turnover from FY23 to FY25 was largely driven by external macro factors, specifically a **60% depreciation** of the Angolan **Kwanza** against the USD, impacting a core export market.
* **Debt Reduction:** Management successfully reduced total borrowings from **₹83.82 crore** (March 2024) to **₹30.59 crore** (March 2025), primarily by settling foreign currency pre-shipment credits.
* **Divestments:** In **June 2025**, the company exited its associations with **Lykis Biscuits Pvt Ltd** and **Lykis Packaging Pvt Ltd**.
* **Trademark Monetization:** In **September 2025**, the Board approved the sale of all company trademarks. These are currently classified as **Assets Held for Sale**, with a fair value exceeding their carrying value on the books.
---
### **Global Operational Footprint & Subsidiary Structure**
Lykis maintains a lean corporate structure designed to facilitate international trade and commission-based agency services.
* **Goldspan Exports Pvt Ltd (100% Subsidiary):** Focuses on FMCG marketing and commission agency services.
* **Lykis Export LLC, UAE (100% Subsidiary):** Acts as the Middle Eastern hub for exporting FMCG, **ENA**, and industrial products.
* **Geographic Strongholds:** While headquartered in **Mumbai** (relocated from West Bengal in 2023), the company’s primary revenue drivers are emerging markets in **Africa** (Congo, Angola, Mozambique) and the **Middle East**.
---
### **Risk Profile & Mitigation Framework**
Investors should note that Lykis operates in a high-beta environment influenced by global geopolitics and currency markets.
* **Geopolitical Disruptions:** Hostilities in the **Red Sea and Gulf of Aden** have escalated freight costs. Regional instability, such as civil unrest in **Mozambique** and border conflicts in the **Congo**, directly impacts volume fulfillment.
* **Currency & Credit Risk:** High exposure to volatile African currencies is mitigated through **Foreign Exchange Forward Contracts** and **Natural Hedges**. Credit risk is managed through a provision for doubtful debts (e.g., **₹1.19 crore** provided in Dec 2023).
* **Market Competition:** The FMCG sector faces aggressive pricing from global players. Lykis is countering this by shifting toward **Ayurveda-based solutions** and **Personal Hygiene** products where brand stickiness is higher.
* **Execution Risk:** The new Acquirers lack direct historical experience in FMCG manufacturing, though they plan to bridge this gap through the existing operational team and PAC directors with logistics expertise.